Medipharm Labs Corp (TSX: LABS )

0.0650 -0.0050 (-7.14%)

Streaming Delayed Price Updated: 3:35 PM EDT, Aug 26, 2024 Add to My Watchlist

Price and Volume

Volume	39,865
Open	0.0700
Bid (Size)	0.0650 (6,690)
Ask (Size)	0.0700 (1,870)
Prev. Close	0.0700
Today's Range	0.0650 - 0.0700
52wk Range	0.0600 - 0.1000
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY

August 14, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...

Via Benzinga

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now

August 09, 2024

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,...

Via Benzinga

Performance

YTD	N/A	N/A
1 Month	-7.14%	-7.14%
3 Month	-18.75%	-18.75%
6 Month	N/A	N/A
1 Year	-13.33%	-13.33%

More News

Executive Changes In Cannabis Industry You Should Know About, New Appointments & More

July 03, 2024

Via Benzinga

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

June 20, 2024

Via Benzinga

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'

May 15, 2024

Via Benzinga

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses

March 27, 2024

Via Benzinga

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil

February 07, 2024

Via Benzinga

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024

December 22, 2023

Via Benzinga

MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report

November 14, 2023

Via Benzinga

MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M

October 02, 2023

Via Benzinga

MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next

September 20, 2023

Via Benzinga

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

December 22, 2022

Via Newsfile

MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO

November 15, 2021

Via Benzinga

MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director

October 21, 2021

Via Benzinga

MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia

August 31, 2021

Via Benzinga

MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY

August 16, 2021

Via Benzinga

MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License

July 14, 2021

Via Benzinga

Another Near Billion-Dollar Cannabis Acquisition Signals More Hyper Valuations to Come

July 09, 2021

Via FinancialNewsMedia

MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma

June 08, 2021

Via Benzinga

MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know

May 17, 2021

Via Benzinga

Number Of Cannabis Patents Granted In Europe & UK Growing At A Quick Pace

April 29, 2021

Via FinancialNewsMedia

Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

April 13, 2021

From IM Cannabis Corp.

Via AccessWire

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

About Us

Medipharm Labs Corp (TSX: LABS )

Price and Volume

Top News

Performance

More News